The Microbeam Insert at the White Beam Beamline P61A at the Synchrotron PETRA III/DESY: A New Tool for High Dose Rate Irradiation Research.

FLASH radiotherapy high dose rate radiotherapy microbeam radiotherapy (MRT) synchrotron

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
20 Oct 2022
Historique:
received: 06 09 2022
revised: 04 10 2022
accepted: 16 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

High dose rate radiotherapies such as FLASH and microbeam radiotherapy (MRT) both have developed to the stage of first veterinary studies within the last decade. With the development of a new research tool for high dose rate radiotherapy at the end station P61A of the synchrotron beamline P61 on the DESY campus in Hamburg, we increased the research capacity in this field to speed up the translation of the radiotherapy techniques which are still experimental, from bench to bedside. At P61, dose rates of several hundred Gy/s can be delivered. Compared to dedicated biomedical beamlines, the beam width available for MRT experiments is a very restrictive factor. We developed two model systems specifically to suit these specific technical parameters and tested them in a first set of experiments.

Identifiants

pubmed: 36291920
pii: cancers14205137
doi: 10.3390/cancers14205137
pmc: PMC9600877
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : German Research Foundation (DFG)
ID : SCHU 2589/7-1
Organisme : German Academic Exchange Service
ID : DAAD PPP 57444927
Organisme : HEREON travel support
ID : no number

Références

BMC Cancer. 2022 May 23;22(1):575
pubmed: 35606739
Proc R Soc Med. 1975 Oct;68(10):653-5
pubmed: 174124
Front Oncol. 2021 May 13;11:658004
pubmed: 34055624
J Synchrotron Radiat. 2022 Mar 1;29(Pt 2):409-423
pubmed: 35254304
Rev Sci Instrum. 2009 Jul;80(7):074301
pubmed: 19655968
PLoS One. 2015 Mar 23;10(3):e0119924
pubmed: 25799425
Phys Med. 2018 Jan;45:156-161
pubmed: 29472081
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1028-33
pubmed: 18280056
J Vet Intern Med. 2021 Jul;35(4):1902-1917
pubmed: 34117807
Radiother Oncol. 2019 Oct;139:18-22
pubmed: 31303340
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):521-525
pubmed: 33383127
Med Phys. 2008 Jul;35(7):3252-8
pubmed: 18697550
Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):967-973
pubmed: 35483539
Sci Rep. 2020 Jun 1;10(1):8833
pubmed: 32483249
Clin Oncol (R Coll Radiol). 2006 May;18(4):293-9
pubmed: 16703746
Clin Cancer Res. 2020 Mar 15;26(6):1497-1506
pubmed: 31796518
J Synchrotron Radiat. 2017 Jul 1;24(Pt 4):854-865
pubmed: 28664893
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1485-1494
pubmed: 27325483
Clin Cancer Res. 2021 Feb 1;27(3):775-784
pubmed: 33060122
Int J Mol Sci. 2022 Sep 01;23(17):
pubmed: 36077349
Cancer. 2016 Jul 1;122(13):2004-11
pubmed: 27028170
J Synchrotron Radiat. 2001 Nov 1;8(Pt 6):1221-8
pubmed: 11679776
Eur J Radiol. 2008 Dec;68(3 Suppl):S142-6
pubmed: 18614312
Sci Transl Med. 2014 Jul 16;6(245):245ra93
pubmed: 25031268
Radiat Res. 2020 Dec 1;194(6):636-645
pubmed: 32853387
Med Phys. 2022 Mar;49(3):2082-2095
pubmed: 34997969
Front Oncol. 2020 Jan 17;9:1563
pubmed: 32010633
Radiat Res. 2021 Oct 1;196(4):355-365
pubmed: 34270776
Cell Mol Biol (Noisy-le-grand). 2000 Sep;46(6):1053-63
pubmed: 10976863
Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):360-369
pubmed: 32088292
Pharmacol Res. 2021 Sep;171:105780
pubmed: 34302977
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1126-1136
pubmed: 31461675
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1053-8
pubmed: 17398023
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10943-10951
pubmed: 31097580
J Synchrotron Radiat. 2012 May;19(Pt 3):332-9
pubmed: 22514166
Int J Clin Oncol. 2021 Sep;26(9):1640-1649
pubmed: 34043101
J Synchrotron Radiat. 2021 Mar 1;28(Pt 2):410-418
pubmed: 33650552
Radiat Oncol. 2018 May 10;13(1):89
pubmed: 29747666
Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1276-1288
pubmed: 34364976
Clin Cancer Res. 2019 Jan 1;25(1):35-42
pubmed: 29875213
Eur J Radiol. 2008 Dec;68(3 Suppl):S114-7
pubmed: 18602783

Auteurs

Elisabeth Schültke (E)

Department of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.

Stefan Fiedler (S)

European Molecular Biology Laboratory (EMBL), Hamburg Outstation, 22607 Hamburg, Germany.

Catharina Mewes (C)

Department of Radiotherapy and Radio-Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Elisabetta Gargioni (E)

Department of Radiotherapy and Radio-Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Johannes Klingenberg (J)

Helmholtz-Zentrum HEREON, 21502 Hamburg, Germany.

Guilherme Abreu Faria (G)

Helmholtz-Zentrum HEREON, 21502 Hamburg, Germany.

Michael Lerch (M)

Centre of Medical Radiation Physics, University of Wollongong, Wollongong 2522, Australia.

Marco Petasecca (M)

Centre of Medical Radiation Physics, University of Wollongong, Wollongong 2522, Australia.

Franziska Prehn (F)

Department of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.

Marie Wegner (M)

Institute of Product Development and Mechanical Engineering Design, Hamburg University of Technology, 21073 Hamburg, Germany.

Marten Scholz (M)

Department of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.

Felix Jaekel (F)

Department of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.

Guido Hildebrandt (G)

Department of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.

Classifications MeSH